Allarity Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Allarity Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Allarity Therapeutics Inc
Rating: 1.75666675
Author: Trendlyne DVM scores

about

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...

1.35 -0.16 (-10.60%)

34.47% Fall from 52W High

258.4K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.7 / 100

Technically Neutral

57.6 / 100

1Yr Price target upside is 622%

1 analysts

Allarity Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Allarity Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...

34.47% Fall from 52W High

SWOT Analysis

Allarity Therapeutics Inc Live Price Chart